Cargando…
Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine
This chapter discusses the current and future applications of monoclonal antibodies against bacteria in veterinary medicine. It discusses the existing applications of monoclonal antibodies, including the use of pilus-specific monoclonal antibodies for passive immunization of calves and piglets again...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155467/ http://dx.doi.org/10.1016/B978-0-12-463003-1.50018-6 |
_version_ | 1783522035648954368 |
---|---|
author | SHERMAN, DAVID M. MARKHAM, R.J.F. |
author_facet | SHERMAN, DAVID M. MARKHAM, R.J.F. |
author_sort | SHERMAN, DAVID M. |
collection | PubMed |
description | This chapter discusses the current and future applications of monoclonal antibodies against bacteria in veterinary medicine. It discusses the existing applications of monoclonal antibodies, including the use of pilus-specific monoclonal antibodies for passive immunization of calves and piglets against enteropathogenic E. coli (EPEC) infections as well as the development of rapid diagnostic test kits for field diagnosis of EPEC infections. The potential applications of monoclonal antibodies for passive immunization against a variety of veterinary pathogens are passive immunization against Moraxella bovis (pinkeye), Bacteroides nodosus (foot rot), EPEC enterotoxin (enteric colibacillosis), Pasteurella haemolytica (pneumonic pasteurellosis), and Streptococcus equi (strangles). Three main areas of application for monoclonal antibodies against bacterial antigens in veterinary medicine are passive immunization, improved immunodiagnostics, and immunotherapy. Monoclonal antibodies, because of their specificity, unlimited availability, and high titer, represent excellent passive immunizing agents. However, their potential usefulness in preventing infection must be evaluated on a case-by-case basis. |
format | Online Article Text |
id | pubmed-7155467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1986 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71554672020-04-15 Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine SHERMAN, DAVID M. MARKHAM, R.J.F. Monoclonal Antibodies Against Bacteria Article This chapter discusses the current and future applications of monoclonal antibodies against bacteria in veterinary medicine. It discusses the existing applications of monoclonal antibodies, including the use of pilus-specific monoclonal antibodies for passive immunization of calves and piglets against enteropathogenic E. coli (EPEC) infections as well as the development of rapid diagnostic test kits for field diagnosis of EPEC infections. The potential applications of monoclonal antibodies for passive immunization against a variety of veterinary pathogens are passive immunization against Moraxella bovis (pinkeye), Bacteroides nodosus (foot rot), EPEC enterotoxin (enteric colibacillosis), Pasteurella haemolytica (pneumonic pasteurellosis), and Streptococcus equi (strangles). Three main areas of application for monoclonal antibodies against bacterial antigens in veterinary medicine are passive immunization, improved immunodiagnostics, and immunotherapy. Monoclonal antibodies, because of their specificity, unlimited availability, and high titer, represent excellent passive immunizing agents. However, their potential usefulness in preventing infection must be evaluated on a case-by-case basis. 1986 2014-06-27 /pmc/articles/PMC7155467/ http://dx.doi.org/10.1016/B978-0-12-463003-1.50018-6 Text en Copyright © 1986 ACADEMIC PRESS, INC. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article SHERMAN, DAVID M. MARKHAM, R.J.F. Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine |
title | Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine |
title_full | Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine |
title_fullStr | Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine |
title_full_unstemmed | Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine |
title_short | Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine |
title_sort | current and future applications of monoclonal antibodies against bacteria in veterinary medicine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155467/ http://dx.doi.org/10.1016/B978-0-12-463003-1.50018-6 |
work_keys_str_mv | AT shermandavidm currentandfutureapplicationsofmonoclonalantibodiesagainstbacteriainveterinarymedicine AT markhamrjf currentandfutureapplicationsofmonoclonalantibodiesagainstbacteriainveterinarymedicine |